Related references
Note: Only part of the references are listed.PRL-3 promotes migration and invasion and is associated with poor prognosis in salivary adenoid cystic carcinoma
Qian Dong et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2016)
Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3
Teresa Rubio et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival
Petra den Hollander et al.
CANCER RESEARCH (2016)
Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration
Esten N. Vandsemb et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Photooxygenation of an amino-thienopyridone yields a more potent PTP4A3 inhibitor
Joseph M. Salamoun et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Identification of proteins suppressing the functions of oncogenic phosphatase of regenerating liver 1 and 3
Ju-Dong Lee et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers
Hamid H. Gari et al.
ONCOTARGET (2016)
PRL3-zumab, a first-in-class humanized antibody for cancer therapy
Min Thura et al.
JCI INSIGHT (2016)
Combined Expression of Metastasis Related Markers Naa10p, SNCG and PRL-3 and its Prognostic Value in Breast Cancer Patients
Li Min et al.
Asian Pacific Journal of Cancer Prevention (2015)
Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study
Henrik Gronberg et al.
LANCET ONCOLOGY (2015)
Procyanidins Negatively Affect the Activity of the Phosphatases of Regenerating Liver
Sven Stadlbauer et al.
PLOS ONE (2015)
PRL-3 activates mTORC1 in Cancer Progression
Zu Ye et al.
SCIENTIFIC REPORTS (2015)
Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
Ke Guo et al.
Oncotarget (2015)
Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver
Birgit Hoeger et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time
Sigve Andersen et al.
BMC UROLOGY (2014)
Upregulation of Protein Tyrosine Phosphatase Type IVA Member 3 (PTP4A3/PRL-3) is Associated with Tumor Differentiation and a Poor Prognosis in Human Hepatocellular Carcinoma
Abudureheman Mayinuer et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells
Garam Min et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Molecular mechanisms of the PRL phosphatases
Pablo Rios et al.
FEBS JOURNAL (2013)
Metastasis-associated PRL-3 induces EGFR activation and addiction in cancer cells
Abdul Qader Omer Al-aidaroos et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
Xiaofang Xing et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Antimetastatic Effect of Halichondramide, a Trisoxazole Macrolide from the Marine Sponge Chondrosia corticata, on Human Prostate Cancer Cells via Modulation of Epithelial-to-Mesenchymal Transition
Yoonho Shin et al.
MARINE DRUGS (2013)
Defining the threshold for significant versus insignificant prostate cancer
Theo H. Van der Kwast et al.
NATURE REVIEWS UROLOGY (2013)
Integrative analysis of prostate cancer aggressiveness
Elisabeth Feik et al.
PROSTATE (2013)
Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity
Young-Min Han et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer
Bala Basak Oven Ustaalioglu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Phosphatase PRL-3 Is a Direct Regulatory Target of TGF beta in Colon Cancer Metastasis
Yanjun Jiang et al.
CANCER RESEARCH (2011)
Expression of phosphatase of regenerating liver-3 in squamous cell carcinoma of the cervix
Yaxi Ma et al.
MEDICAL ONCOLOGY (2011)
VEGF Promotes the Transcription of the Human PRL-3 Gene in HUVEC through Transcription Factor MEF2C
Jianliang Xu et al.
PLOS ONE (2011)
Inhibitory Activities of Anthraquinones from Rubia akane on Phosphatase Regenerating Liver-3
Mi Kyeong Moon et al.
ARCHIVES OF PHARMACAL RESEARCH (2010)
PCBP1 Suppresses the Translation of Metastasis-Associated PRL-3 Phosphatase
Haihe Wang et al.
CANCER CELL (2010)
Prognostic and metastatic value of phosphatase of regenerating liver-3 in invasive breast cancer
Ru-Tian Hao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Expression and Prognostic Value of PRL-3 in Human Intrahepatic Cholangiocarcinoma
Yijun Xu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
High Expression of PRL-3 can Promote Growth of Gastric Cancer and Exhibits a Poor Prognostic Impact on Patients
Zhao Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Prognostic value of PRL-3 overexpression in early stages of colonic cancer
Xiaofang Xing et al.
HISTOPATHOLOGY (2009)
Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma
Jun Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
An Anticancer Effect of Curcumin Mediated by Down-Regulating Phosphatase of Regenerating Liver-3 Expression on Highly Metastatic Melanoma Cells
Lu Wang et al.
MOLECULAR PHARMACOLOGY (2009)
PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer
Jian Ming et al.
PATHOLOGY (2009)
Prognostic Significance of Phosphatase of Regenerating Liver-3 Expression in Ovarian Cancer
Tingting Ren et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer
Ni Da et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells
Unn-Merete Fagerli et al.
BLOOD (2008)
PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness
D. G. Mollevi et al.
BRITISH JOURNAL OF CANCER (2008)
PRL PTPs: mediators and markers of cancer progression
Darrell C. Bessette et al.
CANCER AND METASTASIS REVIEWS (2008)
A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage
Sherif Daouti et al.
CANCER RESEARCH (2008)
Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase
Fubo Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis
Ying Wang et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis
Zheng-Rong Li et al.
SURGERY TODAY (2007)
High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies:: an in situ hybridization study
U. A. Miskad et al.
VIRCHOWS ARCHIV (2007)
Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome
L. Wang et al.
ANNALS OF ONCOLOGY (2006)
Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
I. Radke et al.
BRITISH JOURNAL OF CANCER (2006)
Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors
JH Ahn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Biflavonoids inhibited phosphatase of regenerating liver-3 (PRL-3)
Sung-Kyu Choi et al.
NATURAL PRODUCT RESEARCH (2006)
PRL-3 phosphatase is implicated in ovarian cancer growth
F Polato et al.
CLINICAL CANCER RESEARCH (2005)
Generation of PRIL-3-and PRIL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases
J Li et al.
CLINICAL CANCER RESEARCH (2005)
The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer
LR Peng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
A phosphatase associated with metastasis of colorectal cancer
S Saha et al.
SCIENCE (2001)
Share Paper
